{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T03:45:12Z","timestamp":1775187912153,"version":"3.50.1"},"reference-count":18,"publisher":"Hindawi Limited","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":124,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/100015661","name":"UCB Pharma","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100015661","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Neurol Scand"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1111\/ane.12416","type":"journal-article","created":{"date-parts":[[2015,4,30]],"date-time":"2015-04-30T11:29:12Z","timestamp":1430393352000},"page":"346-354","source":"Crossref","is-referenced-by-count":23,"title":["Lacosamide cardiac safety: a thorough QT\/QTc trial in healthy volunteers"],"prefix":"10.1155","volume":"132","author":[{"given":"D.","family":"Kropeit","sequence":"first","affiliation":[{"name":"AiCuris GmbH & Co. KG; Wuppertal Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Johnson","sequence":"additional","affiliation":[{"name":"UCB Pharma; Raleigh NC USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Cawello","sequence":"additional","affiliation":[{"name":"UCB Pharma; Monheim am Rhein Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. D.","family":"Rudd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Horstmann","sequence":"additional","affiliation":[{"name":"Consulting Early Development; Bonn Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"98","published-online":{"date-parts":[[2015,4,30]]},"reference":[{"key":"10.1111\/ane.12416-BIB0001|ane12416-cit-0001","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/nyas.12213","article-title":"Development of lacosamide for the treatment of partial-onset seizures","volume":"1291","author":"Doty","year":"2013","journal-title":"Ann N Y Acad Sci"},{"key":"10.1111\/ane.12416-BIB0002|ane12416-cit-0002","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1124\/mol.107.039867","article-title":"The investigational anticonvulsant lacosamide selectively enhances slow inactivation of voltage-gated sodium channels","volume":"73","author":"Errington","year":"2008","journal-title":"Mol Pharmacol"},{"key":"10.1111\/ane.12416-BIB0003|ane12416-cit-0003","unstructured":"VIMPAT \u00ae . (lacosamide) Prescribing Information 2014"},{"key":"10.1111\/ane.12416-BIB0004|ane12416-cit-0004","unstructured":"VIMPAT \u00ae . (lacosamide) Summary of Product Characteristics 2014"},{"key":"10.1111\/ane.12416-BIB0005|ane12416-cit-0005","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s40261-014-0177-2","article-title":"Pharmacokinetics of lacosamide and omeprazole coadministration in healthy volunteers: results from a phase I, randomized, crossover trial","volume":"34","author":"Cawello","year":"2014","journal-title":"Clin Drug Invest"},{"key":"10.1111\/ane.12416-BIB0006|ane12416-cit-0006","doi-asserted-by":"crossref","first-page":"P01.076","DOI":"10.1212\/WNL.78.1_MeetingAbstracts.P01.076","article-title":"Lacosamide has no effect on the enzymatic activity of CYP3A4","volume":"78","author":"Cawello","year":"2012","journal-title":"Neurology"},{"key":"10.1111\/ane.12416-BIB0007|ane12416-cit-0007","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/s40262-013-0080-7","article-title":"Impact of impaired renal function on the pharmacokinetics of the antiepileptic drug lacosamide","volume":"52","author":"Cawello","year":"2013","journal-title":"Clin Pharmacokinet"},{"key":"10.1111\/ane.12416-BIB0008|ane12416-cit-0008","doi-asserted-by":"crossref","DOI":"10.1111\/ane.12413","article-title":"Cardiac safety of lacosamide: the non-clinical perspective","author":"Delaunois","year":"2015","journal-title":"Acta Neurol Scand"},{"key":"10.1111\/ane.12416-BIB0009|ane12416-cit-0009","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0008-6363(02)00846-5","article-title":"Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development","volume":"58","author":"Redfern","year":"2003","journal-title":"Cardiovasc Res"},{"key":"10.1111\/ane.12416-BIB0010|ane12416-cit-0010","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.2165\/11586830-000000000-00000","article-title":"Examining the clinical utility of lacosamide: pooled analyses of three phase II\/III clinical trials","volume":"24","author":"Chung","year":"2010","journal-title":"CNS Drugs"},{"key":"10.1111\/ane.12416-BIB0011|ane12416-cit-0011","doi-asserted-by":"crossref","DOI":"10.1111\/ane.12414","article-title":"Lacosamide cardiac safety: clinical trials in patients with partial-onset seizures","author":"Rudd","year":"2015","journal-title":"Acta Neurol Scand"},{"key":"10.1111\/ane.12416-BIB0012|ane12416-cit-0012","unstructured":"ICH Guidance for Industry http:\/\/www.fda.gov\/downloads\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/UCM073161.pdf 2005"},{"key":"10.1111\/ane.12416-BIB0013|ane12416-cit-0013","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/j.1365-2125.2008.03250.x","article-title":"Lamotrigine does not prolong QTc in a thorough QT\/QTc study in healthy subjects","volume":"66","author":"Dixon","year":"2008","journal-title":"Br J Clin Pharmacol"},{"key":"10.1111\/ane.12416-BIB0014|ane12416-cit-0014","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1177\/0091270010391789","article-title":"Evaluation of eslicarbazepine acetate on cardiac repolarization in a thorough QT\/QTc study","volume":"52","author":"Vaz-Da-Silva","year":"2012","journal-title":"J Clin Pharmacol"},{"key":"10.1111\/ane.12416-BIB0015|ane12416-cit-0015","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/BF00878554","article-title":"Electrophysiological evaluation of the sodium-channel blocker carbamazepine in healthy human subjects","volume":"9","author":"Kenneback","year":"1995","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1111\/ane.12416-BIB0016|ane12416-cit-0016","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1111\/j.1365-2125.2010.03855.x","article-title":"Effect of lamotrigine on the PR interval in healthy subjects","volume":"71","author":"Dixon","year":"2011","journal-title":"Br J Clin Pharmacol"},{"key":"10.1111\/ane.12416-BIB0017|ane12416-cit-0017","unstructured":"LYRICA \u00ae . (pregabalin) Prescribing Information Pfizer NY, USA 2012"},{"key":"10.1111\/ane.12416-BIB0018|ane12416-cit-0018","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1177\/0091270009347675","article-title":"No Pharmacokinetic Interaction Between Lacosamide and Carbamazepine in Healthy Volunteers","volume":"50","author":"Cawello","year":"2009","journal-title":"J Clin Pharmacol"}],"container-title":["Acta Neurologica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fane.12416","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/ane.12416\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T12:48:24Z","timestamp":1671540504000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ane.12416"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,30]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,11]]}},"URL":"https:\/\/doi.org\/10.1111\/ane.12416","archive":["Portico"],"relation":{},"ISSN":["0001-6314"],"issn-type":[{"value":"0001-6314","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4,30]]}}}